Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer
Steffen Weikert(St. Hedwig-Krankenhaus), Markus Müller(Charité - Universitätsmedizin Berlin), Frank Christoph(Charité - Universitätsmedizin Berlin), Ingmar Wolff(Universitätsmedizin Greifswald), Thomas Emrich(Roche Pharma AG (Germany)), Mark Schrader(Arbeitsgemeinschaft Urologische Onkologie), Kurt Miller(Charité - Universitätsmedizin Berlin), Hans Krause(Charité - Universitätsmedizin Berlin)
Cited by 42
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594